A clinical trial is far from done once the last trial participant completes the last visit and the database is locked; there’s still a long list of tasks and procedures to work through, from accounting for leftover investigational product to wrapping up final reports. Failing to conduct all of those closeout activities can put a site out of compliance with FDA regulations, IRB requirements, the contract with the sponsor or even their own established policies and procedures.